{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:18:33Z","timestamp":1783048713420,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA060142"],"award-info":[{"award-number":["T32DA060142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pbb.2026.174201","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:01:24Z","timestamp":1777993284000},"page":"174201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The abuse-related effects of illicitly manufactured fentanyls (IMFs): A mini review"],"prefix":"10.1016","volume":"265","author":[{"given":"Jeremy R.","family":"Canfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E.","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2026.174201_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174074","article-title":"Reinforcing and psychostimulant effects of carfentanil and morphine in mice","volume":"255","author":"An","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.pbb.2026.174201_bb0010","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1021\/acschemneuro.8b00174","article-title":"Dark classics in chemical neuroscience: Fentanyl","volume":"9","author":"Burns","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.pbb.2026.174201_bb0015","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/dta.3636","article-title":"Influence of carbon side chain length on the in vivo pharmacokinetic and pharmacodynamic characteristics of illicitly manufactured fentanyls","volume":"16","author":"Canfield","year":"2023","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.pbb.2026.174201_bb0020","author":"Centers for Disease Control and Prevention"},{"issue":"9","key":"10.1016\/j.pbb.2026.174201_bb0025","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00213-025-06790-2","article-title":"Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl","volume":"242","author":"Chen","year":"2025","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2026.174201_bb0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.pbb.2026.174201_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108530","article-title":"Potential unintended consequences of class-wide drug scheduling based on chemical structure: A cautionary tale for fentanyl-related compounds","volume":"221","author":"Comer","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2026.174201_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110002","article-title":"Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pKa fluorinated fentanyl analogs, FF3 and NFEPP","volume":"255","author":"Edwards","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2026.174201_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2026.174201_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108599","article-title":"Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone","volume":"221","author":"Flynn","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.pbb.2026.174201_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.121.000912","article-title":"Characterization of the discriminative stimulus effects of binary mixtures of mu opioid receptor agonists in rats discriminating fentanyl","volume":"380","author":"Flynn","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.cr.7290148","article-title":"Ohmefentanyl stereoisomers induce changes of CREB phosphorylation in hippocampus of mice in conditioned place preference paradigm","volume":"13","author":"Gao","year":"2003","journal-title":"Cell Res."},{"issue":"21","key":"10.1016\/j.pbb.2026.174201_bb0065","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0024-3205(01)01030-X","article-title":"Quantitative comparison of ohmefentanyl isomers induced conditioning place preference in mice","volume":"68","author":"Guo","year":"2001","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.pbb.2026.174201_bb0070","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/dta.2822","article-title":"in vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis","volume":"12","author":"Hassanien","year":"2020","journal-title":"Drug Test Anal."},{"issue":"7","key":"10.1016\/j.pbb.2026.174201_bb0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/02698811251330780","article-title":"Discriminating evidence \u2013 use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs","volume":"39","author":"Heal","year":"2025","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2026.174201_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-019-3999-2","article-title":"Molecular dynamics of fentanyl bound to \u03bc-opioid receptor","volume":"25","author":"Lipi\u0144ski","year":"2019","journal-title":"J. Mol. Model."},{"issue":"11","key":"10.1016\/j.pbb.2026.174201_bb0085","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00213-024-06641-6","article-title":"Reinforcing effects of fentanyl analogs found in illicit drug markets","volume":"241","author":"Maitland","year":"2024","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2026.174201_bb0090","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2026.174201_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110603","article-title":"In vitro and in vivo pharmacological characterization of fentanyl analogs","volume":"279","author":"Obeng","year":"2025","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Review: Behavioural assessment of drug reinforcement and addictive features in rodents: An Overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addctn. Biol."},{"issue":"6328","key":"10.1016\/j.pbb.2026.174201_bb0105","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.aai8636","article-title":"A nontoxic pain killer designed by modeling of pathological receptor conformations","volume":"355","author":"Spahn","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27313-4","article-title":"Opioid receptor signaling, analgesic and side effects induced by a computationally designed ph-dependent agonist","volume":"8","author":"Spahn","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.pbb.2026.174201_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4155\/fmc.13.215","article-title":"Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications","volume":"6","author":"Vardanyan","year":"2014","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21262-9","article-title":"How \u03bc-opioid receptor recognizes fentanyl","volume":"12","author":"Vo","year":"2021","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.pbb.2026.174201_bb0125","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2174\/092986709788682074","article-title":"Fentanyl analogs: structure-activity-relationship study","volume":"16","author":"Vuckovic","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pbb.2026.174201_bb0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2019.02.007","article-title":"Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice","volume":"150","author":"Walentiny","year":"2019","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.121.000689","article-title":"Antinociceptive and discriminative stimulus effects of six novel psychoactive opioid substances in male rats","volume":"379","author":"Walker","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2026.174201_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110509","article-title":"Effects of novel fentanyl derivatives in rats trained to discriminate morphine","volume":"276","author":"Walker","year":"2025","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2026.174201_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13265","article-title":"Assessment of abuse potential of carfentanil","volume":"28","author":"Wei","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2026.174201_bb0150","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.csbj.2022.05.013","article-title":"A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the \u03bc-opioid receptor","volume":"20","author":"Xie","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.pbb.2026.174201_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-024-06664-z","article-title":"Isobutyryl-carfentanyl has strong acute toxicity and analgesic effects with high addiction potential","volume":"242","author":"Xu","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2026.174201_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/jat.70103","article-title":"Comparative study of analgesic therapeutic index and addiction potential of O- and p-fluorofentanyl","author":"Xu","year":"2026","journal-title":"J. Appl. Toxicol."},{"issue":"23","key":"10.1016\/j.pbb.2026.174201_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human \u03bc-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305726000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:51:14Z","timestamp":1783047074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305726000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S0091305726000560"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174201","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The abuse-related effects of illicitly manufactured fentanyls (IMFs): A mini review","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2026.174201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"174201"}}